Tunisia

In Tunisia, the primary regulatory authority responsible for health products, including pharmaceuticals, medical devices, diagnostics, and increasingly digital health solutions, is the Direction de la Pharmacie et du Médicament (DPM), operating under the Ministry of Health. The principal governing legislation includes the Code de la Santé Publique and Law No. 85-91 of 1985 on pharmaceutical regulation, along with subsequent decrees and ministerial orders that have updated the framework over time. The DPM oversees market authorization (Autorisation de Mise sur le Marché, AMM) for pharmaceuticals, while medical devices and diagnostics are subject to specific registration procedures that have been progressively formalized. All health products intended for the Tunisian market must receive approval before commercialization, with the DPM conducting technical and administrative review of submitted dossiers.

For pharmaceutical submissions, Tunisia generally follows the Common Technical Document (CTD) format, aligned with international standards, although adaptations and additional local documentation are frequently required. Applicants must appoint a locally registered representative or importer, as foreign manufacturers cannot directly register products without a Tunisian-based entity acting on their behalf. Medical devices require technical file submissions demonstrating conformity, with CE marking from recognized notified bodies often serving as a supporting reference, though it does not replace local registration. Recent reforms have focused on accelerating registration timelines for priority medicines, including generic drugs and products addressing public health needs, as well as developing clearer frameworks for in-vitro diagnostics and digital health tools. The DPM has also engaged with regional harmonization initiatives within the African context, including alignment efforts with the African Medicines Agency (AMA) framework.

Public procurement of health products in Tunisia is centralized through the Pharmacie Centrale de Tunisie (PCT), a state-owned entity that serves as the principal purchasing and distribution body for pharmaceuticals, medical devices, and diagnostics destined for public health facilities. The PCT conducts national tenders on behalf of the Ministry of Health, with procurement governed by the public procurement regulations set out in the Tunisian Procurement Code (Decree No. 2014-1039 and its amendments). Tenders are typically open to registered suppliers and importers, and award criteria generally consider price, product quality, and compliance with registration requirements. Regional health directorates and public hospitals may also conduct supplementary local procurement for specific needs, but the PCT remains the dominant channel for bulk public-sector supply. Budget constraints and delays in tender cycles have historically affected the reliability and predictability of public procurement timelines.

The private sector constitutes a significant and growing channel for health product distribution in Tunisia, operating through a network of licensed wholesalers, distributors, and retail pharmacies. Private sector procurement follows commercial negotiation processes independent of PCT tenders, providing manufacturers with a parallel market entry route. Tunisia also benefits from donor-funded procurement programs, particularly for communicable diseases and maternal and child health priorities: organizations such as UNICEF, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and bilateral donors have historically supported procurement of specific health commodities outside standard government channels, though Tunisia's middle-income status limits the scope of such support compared to lower-income countries. Local manufacturing is encouraged through government policy, with locally produced products sometimes granted preferential considerations in public tenders, reflecting Tunisia's broader industrial strategy to develop domestic pharmaceutical manufacturing capacity and reduce import dependency.